Teva: Is Another Dividend Cut In The Cards?

Through the first half of 2017 Teva's free cash flow has free fallen. The company recently cut its dividend to stem cash burn. Generic Copaxone could cause free cash flow to turn negative. Is another dividend cut in the cards?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.